Tags

Type your tag names separated by a space and hit enter

Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study.
Am J Prev Med. 2017 Jul; 53(1):e1-e7.AJ

Abstract

INTRODUCTION

Tobacco use among transgender adults continues to be an area of research with few reported findings. The limited literature indicates higher cigarette use among transgender adults, compared with the general population. This national study is the first to report on cigarettes, cigars, and e-cigarettes by examining differences in transgender tobacco use independent of sexual orientation.

METHODS

Data were collected in 2013 using a nationally cross-sectional online survey of U.S. adults (cisgender, n=17,164; transgender, n=168) and analyzed in 2015. Past 30-day tobacco use point estimates and adjusted logistic regression while controlling for false discovery rate were reported for transgender and cisgender respondents.

RESULTS

Transgender adults reported higher past 30-day use of any cigarette/cigar/e-cigarette product (39.7% vs 25.1%) and current use of cigarettes (35.5% vs 20.7%), cigars (26.8% vs 9.3%), and e-cigarettes (21.3% vs 5.0%) compared with cisgender adults (all p-values ≤0.003). Transgender respondents had significantly higher odds of past 30-day tobacco product use for any cigarette/cigar/e-cigarette product (OR=1.97, 95% CI=1.25, 3.1), e-cigarettes (OR=5.15, 95% CI=3.36, 7.88), cigars (OR=3.56, 95% CI=2.27, 5.59), and cigarettes (OR=2.10, 95% CI=1.35, 3.28) versus cisgender respondents (all p-values ≤0.0035).

CONCLUSIONS

Transgender adults are at higher risk for tobacco use than cisgender adults and risk of specific product use varies by gender. This is the first U.S. national study to assess differences in use of various tobacco products using questions that specifically ask for gender identity separately from sexual orientation. This study provides data that can inform targeted interventions to promote transgender health.

Authors+Show Affiliations

Horizons Foundation, San Francisco, California. Electronic address: franciscobuchting@outlook.com.Moores Cancer Center at the University of California, San Diego, San Diego, California.Boston University School of Public Health, Boston, Massachusetts.National Opinion Research Center at the University of Chicago, Chicago, Illinois.Fay W. Boozman College of Public Health at the University of Arkansas for Medical Sciences, Little Rock, Arkansas.VeraCite Inc., San Diego, California.National Opinion Research Center at the University of Chicago, Chicago, Illinois.

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

28094133

Citation

Buchting, Francisco O., et al. "Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study." American Journal of Preventive Medicine, vol. 53, no. 1, 2017, pp. e1-e7.
Buchting FO, Emory KT, Scout , et al. Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study. Am J Prev Med. 2017;53(1):e1-e7.
Buchting, F. O., Emory, K. T., Scout, ., Kim, Y., Fagan, P., Vera, L. E., & Emery, S. (2017). Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study. American Journal of Preventive Medicine, 53(1), e1-e7. https://doi.org/10.1016/j.amepre.2016.11.022
Buchting FO, et al. Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study. Am J Prev Med. 2017;53(1):e1-e7. PubMed PMID: 28094133.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study. AU - Buchting,Francisco O, AU - Emory,Kristen T, AU - Scout,, AU - Kim,Yoonsang, AU - Fagan,Pebbles, AU - Vera,Lisa E, AU - Emery,Sherry, Y1 - 2017/01/13/ PY - 2016/07/06/received PY - 2016/10/27/revised PY - 2016/11/18/accepted PY - 2017/1/18/pubmed PY - 2018/4/3/medline PY - 2017/1/18/entrez SP - e1 EP - e7 JF - American journal of preventive medicine JO - Am J Prev Med VL - 53 IS - 1 N2 - INTRODUCTION: Tobacco use among transgender adults continues to be an area of research with few reported findings. The limited literature indicates higher cigarette use among transgender adults, compared with the general population. This national study is the first to report on cigarettes, cigars, and e-cigarettes by examining differences in transgender tobacco use independent of sexual orientation. METHODS: Data were collected in 2013 using a nationally cross-sectional online survey of U.S. adults (cisgender, n=17,164; transgender, n=168) and analyzed in 2015. Past 30-day tobacco use point estimates and adjusted logistic regression while controlling for false discovery rate were reported for transgender and cisgender respondents. RESULTS: Transgender adults reported higher past 30-day use of any cigarette/cigar/e-cigarette product (39.7% vs 25.1%) and current use of cigarettes (35.5% vs 20.7%), cigars (26.8% vs 9.3%), and e-cigarettes (21.3% vs 5.0%) compared with cisgender adults (all p-values ≤0.003). Transgender respondents had significantly higher odds of past 30-day tobacco product use for any cigarette/cigar/e-cigarette product (OR=1.97, 95% CI=1.25, 3.1), e-cigarettes (OR=5.15, 95% CI=3.36, 7.88), cigars (OR=3.56, 95% CI=2.27, 5.59), and cigarettes (OR=2.10, 95% CI=1.35, 3.28) versus cisgender respondents (all p-values ≤0.0035). CONCLUSIONS: Transgender adults are at higher risk for tobacco use than cisgender adults and risk of specific product use varies by gender. This is the first U.S. national study to assess differences in use of various tobacco products using questions that specifically ask for gender identity separately from sexual orientation. This study provides data that can inform targeted interventions to promote transgender health. SN - 1873-2607 UR - https://www.unboundmedicine.com/medline/citation/28094133/Transgender_Use_of_Cigarettes_Cigars_and_E_Cigarettes_in_a_National_Study_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0749-3797(16)30623-7 DB - PRIME DP - Unbound Medicine ER -